Twist Bioscience
IPO
We lead innovation in DNA synthesis
- Headquarters
- South San Francisco, California
- Employees
- 1001–5000
- Founded
- 2013
- Business Model
- B2B
- Website
- twistbioscience.com
- Total Funding
- $193.1M
- Last Round
- $27.0M Extension RoundJun 2017
About
Twist Bioscience developed a proprietary semiconductor-based DNA synthesis platform that miniaturizes chemistry using silicon chips with 10,000 nanowells. The company manufactures synthetic genes, oligo pools, NGS target enrichment kits, variant libraries, and antibody discovery tools. Its products serve researchers across therapeutics, diagnostics, agriculture, data storage, and industrial biotechnology worldwide.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account